15:56 JST, April 4, 2024
ORTUCCHIO, Italy (Reuters) — A space center in the heart of Italy is set to host the main control site for the low-orbit IRIS² (pronounced ‘Iris squared’) EU satellite constellation, Italy’s industry minister said last month.
The Fucino Space Centre, close to the town of l’Aquila and one of the world’s largest space centers for civilian use, will be expanded to include control operations for IRIS², Adolfo Urso told a press conference.
The center already manages the European satellite positioning and navigation system Galileo.
IRIS² is designed to compete with Elon Musk’s Starlink and Jeff Bezos’ Kuiper.
It is an array of up to 170 satellites that will secure communications for European Union governments and open new commercial broadband services to under-served areas between 2025 and 2027.
“IRIS² will be the European answer to low-Earth-orbit constellations, which are becoming the future of telecoms,” said Franco Ongaro, Chief Space Business Officer for Italian aerospace and defense conglomerate Leonardo.
The Fucino site is owned by Telespazio, jointly controlled 67%-33% by Leonardo and France’s Thales respectively.
“It [IRIS²] is a critical [piece of] infrastructure for the country, as it enables a series of operations relevant to aspects of national security,” Telespazio CEO Luigi Pasquali said.
Urso added that €50 million ($54 million) would be invested and 200 new jobs created at the Fucino center.
Ongaro added that the EU is expected to assign the first contracts for IRIS² as soon as this year.
The EU has pledged that 30% of the EU-funded part of IRIS², which is worth €2.4 billion, will be allocated to small firms.
Top Articles in Science & Nature
-
Japan Institute to Use Domestic Commercial Optical Lattice Clock to Set Japan Standard Time
-
Japan to Face Shortfall of 3.39 Million Workers in AI, Robotics in 2040; Clerical Workers Seen to Be in Surplus
-
Record 700 Startups to Gather at SusHi Tech Tokyo in April; Event Will Center on Themes Like Artificial Intelligence and Robotics
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed
-
iPS Cell Products for Parkinson’s, Heart Disease OK’d for Commercialization by Japan Health Ministry Panel
JN ACCESS RANKING
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Japan Institute to Use Domestic Commercial Optical Lattice Clock to Set Japan Standard Time
-
Israeli Ambassador to Japan Speaks about Japan’s Role in the Reconstruction of Gaza
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Videos Plagiarized, Reposted with False Subtitles Claiming ‘Ryukyu Belongs to China’; Anti-China False Information Also Posted in Japan

